A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease

C.E. Patterson, A.P. Passmore, V.L.S. Crawford

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Nursing and Health Professions